Eton Pharmaceuticals, Inc.
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Sep 2017 | — | — | $14.2M |
| Dec 2017 | $1.3M | $13.4M | $13.2M |
| Mar 2018 | — | — | $11.2M |
| Sep 2018 | $2.8M | $7.5M | $6.6M |
| Dec 2018 | $2.0M | $28.3M | $26.7M |
| Mar 2019 | $3.8M | $23.0M | $19.6M |
| Jun 2019 | $1.5M | $18.2M | $14.9M |
| Sep 2019 | $1.2M | $13.5M | $11.8M |
| Dec 2019 | $6.5M | $17.1M | $12.1M |
| Mar 2020 | $6.6M | $17.2M | $12.3M |
| Jun 2020 | $7.5M | $14.6M | $10.3M |
| Sep 2020 | $10.0M | $11.4M | $7.3M |
| Dec 2020 | $10.7M | $26.3M | $21.3M |
| Mar 2021 | $9.6M | $31.2M | $25.1M |
| Jun 2021 | $9.2M | $29.9M | $25.8M |
| Sep 2021 | $10.9M | $26.6M | $22.7M |
| Dec 2021 | $9.8M | $27.5M | $14.4M |
| Mar 2022 | $9.8M | $23.2M | $15.2M |
| Jun 2022 | $9.8M | $23.0M | $17.0M |
| Sep 2022 | $10.3M | $21.5M | $13.4M |
| Dec 2022 | $12.0M | $25.0M | $16.3M |
| Mar 2023 | $12.7M | $23.9M | $14.7M |
| Jun 2023 | $14.2M | $30.9M | $21.6M |
| Sep 2023 | $14.6M | $31.5M | $22.1M |
| Dec 2023 | $16.3M | $31.7M | $21.4M |
| Mar 2024 | $15.3M | $30.8M | $16.7M |
| Jun 2024 | $18.4M | $31.8M | $17.7M |
| Sep 2024 | $19.9M | $35.8M | $20.3M |
| Dec 2024 | $51.7M | $76.1M | $14.9M |
| Mar 2025 | $59.6M | $84.0M | $17.4M |
| Jun 2025 | $77.7M | $101.7M | $25.4M |
| Sep 2025 | $81.4M | $104.5M | $37.1M |
| Dec 2025 | $66.0M | $92.1M | $25.9M |
| Mar 2026 | $67.1M | $97.7M | $19.7M |
| Jun 2026 | $69.2M | $115.8M | $26.8M |